B. 1. Badesch, D. Champion, H. Sanchez, and M. , Diagnosis and Assessment of Pulmonary Arterial Hypertension, Journal of the American College of Cardiology, vol.54, issue.1, pp.55-66, 2009.
DOI : 10.1016/j.jacc.2009.04.011

A. Chaouat, E. Weitzenblum, and T. Higenbottam, The role of thrombosis in severe pulmonary hypertension, European Respiratory Journal, vol.9, issue.2, pp.356-63, 1996.
DOI : 10.1183/09031936.96.09020356

A. Lopes, L. Caramuru, and N. Maeda, Endothelial Dysfunction Associated with Chronic Intravascular Coagulation in Secondary Pulmonary Hypertension, Clinical and Applied Thrombosis/Hemostasis, vol.144, issue.4, pp.353-361, 2002.
DOI : 10.1002/jcp.1041620207

G. Christ, S. Graf, and R. Huber-beckmann, Impairment of the plasmin activation system in primary pulmonary hypertension: evidence for gender differences, Thromb Haemost, vol.86, issue.2, pp.557-62, 2001.

P. Eisenberg, C. Lucore, and L. Kaufman, Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension, Circulation, vol.82, issue.3, pp.841-848, 1990.
DOI : 10.1161/01.CIR.82.3.841

C. Welsh, K. Hassell, and D. Badesch, Coagulation and Fibrinolytic Profiles in Patients With Severe Pulmonary Hypertension, Chest, vol.110, issue.3, pp.710-717, 1996.
DOI : 10.1378/chest.110.3.710

M. Hoeper, M. Sosada, and H. Fabel, Plasma coagulation profiles in patients with severe primary pulmonary hypertension, European Respiratory Journal, vol.12, issue.6, pp.1446-1455, 1998.
DOI : 10.1183/09031936.98.12061446

A. Lopes, N. Maeda, and V. Aiello, Abnormal Multimeric and Oligomeric Composition Is Associated With Enhanced Endothelial Expression of von Willebrand Factor in Pulmonary Hypertension, Chest, vol.104, issue.5, pp.1455-60, 1993.
DOI : 10.1378/chest.104.5.1455

A. Lopes, N. Maeda, and R. Goncalves, Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension, Am Heart J Am J Med, vol.139105, issue.11393, pp.618-2321, 1998.

C. Wagenvoort, . Anatomie-pathologique-de-la-circulation-pulmonaire, D. Babuty, and C. Boulanger, Hypertension artérielle pulmonaire, Paris; 1993. 13. Hypertension artérielle pulmonaire -La prise en charge multidisciplinaire Endothelial function and dysfunction: testing and clinical relevance, Circulation, vol.115, pp.1285-95, 2003.

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14
DOI : 10.1056/NEJMra040291

URL : https://hal.archives-ouvertes.fr/hal-01455600

J. Crawley and D. Lane, The Haemostatic Role of Tissue Factor Pathway Inhibitor, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.2
DOI : 10.1161/ATVBAHA.107.141606

D. Pollak, E. Buck, and C. , Endothelial cells in physiology and in the pathophysiology of vascular disorders, Arterioscler Thromb Vasc Biol Feb Blood, vol.2891, issue.2010, pp.233-423527, 1998.

H. Bounameaux, P. De-moerloose, and A. Perrier, D-dimer testing in suspected venous thromboembolism: an update, QJM, vol.90, issue.7, pp.437-479, 1997.
DOI : 10.1093/qjmed/90.7.437

J. Kelly, A. Rudd, and R. Lewis, Plasma D-dimers in the diagnosis of venous thromboembolism Non-invasive diagnosis of venous thromboembolism in outpatients, Arch Intern Med Lancet, vol.162353, issue.239148, pp.747-56190, 1999.

M. Righini and A. Perrier, Dosage des D-dim??res et risque de r??cidive thromboembolique veineuse, La Revue de M??decine Interne, vol.29, issue.6, pp.476-81, 2008.
DOI : 10.1016/j.revmed.2007.12.012

S. Eichinger, E. Minar, and C. Bialonczyk, D-dimer levels and risk of recurrent venous thromboembolism1071-4. 26. Tripodi A, Mannucci PM. Markers of activated coagulation and their usefulness in the clinical laboratory, JAMA Clin Chem, vol.29042, issue.85, pp.664-673, 1996.

A. Hobson, R. Agarwala, and R. Swallow, Thrombelastography: current clinical applications and its potential role in interventional cardiology Thrombin generation, a function test of the haemostatic-thrombotic system, Platelets Thromb Haemost, vol.1796, issue.285, pp.509-18553, 2006.

N. Hezard, L. Bouaziz-borgi, and M. Remy, Utility of Thrombin-Generation Assay in the Screening of Factor V G1691A (Leiden) and Prothrombin G20210A Mutations and Protein S Deficiency, Clinical Chemistry, vol.52, issue.4, pp.665-70, 2006.
DOI : 10.1373/clinchem.2005.063339

G. Lavigne-lissalde, C. Sanchez, and C. Castelli, In prothrombin G20210A carriers the genetic mutation and the history of Venous Thrombosis contribute both to thrombin generation independently of factor II plasma levels, Journal of Thrombosis and Haemostasis, vol.8, issue.5, pp.942-951
DOI : 10.1111/j.1538-7836.2010.03773.x

P. Simioni, E. Castoldi, and B. Lunghi, An underestimated combination of opposites resulting in enhanced thrombotic tendency Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence, Blood Br J Haematol, vol.106138, issue.76, pp.2363-5769, 2005.

V. Regnault, H. Hemker, and D. Wahl, Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk Tripodi A, Martinelli I, Chantarangkul V, et al. The endogenous thrombin potential and the risk of venous thromboembolism, Thromb Res Thromb Res, vol.114121, issue.343, pp.5-6539, 2004.

J. Duchemin, B. Pan-petesch, and B. Arnaud, Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma, Thromb Haemost, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00685463

A. Dielis, E. Castoldi, and H. Spronk, Coagulation factors and the protein C system as determinants of thrombin generation in a normal population Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram, J Thromb Haemost Thromb Haemost, vol.996102, issue.375, pp.767-73125, 2008.

G. Simonneau, I. Robbins, and M. Beghetti, Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol Jun, vol.3054, issue.1, pp.43-54, 2009.

R. Machado, O. Eickelberg, and C. Elliott, Genetics and Genomics of Pulmonary Arterial Hypertension, Journal of the American College of Cardiology, vol.54, issue.1, pp.32-42, 2009.
DOI : 10.1016/j.jacc.2009.04.015

P. Herve, J. Launay, and M. Scrobohaci, Increased plasma serotonin in primary pulmonary hypertension, The American Journal of Medicine, vol.99, issue.3, pp.249-54, 1995.
DOI : 10.1016/S0002-9343(99)80156-9

S. Eddahibi, A. Chaouat, and N. Morrell, Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease, Circulation, vol.108, issue.15, 2003.
DOI : 10.1161/01.CIR.0000091409.53101.E8

M. Humbert, F. Perros, M. Karmochkine, and R. Dorent, Biopatholgie de l'hypertension artérielle pulmoanire Plasma levels of thrombomodulin in pulmonary hypertension, Am J Med, vol.101, issue.2, pp.160-164, 1996.

F. Sakamaki, S. Kyotani, and N. Nagaya, Increased Plasma P-Selectin and Decreased Thrombomodulin in Pulmonary Arterial Hypertension Were Improved by Continuous Prostacyclin Therapy, Circulation, vol.102, issue.22, pp.2720-2725, 2000.
DOI : 10.1161/01.CIR.102.22.2720

R. Stratton, L. Pompon, and J. Coghlan, Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension, Annals of the Rheumatic Diseases, vol.59, issue.2, 2000.
DOI : 10.1136/ard.59.2.132

F. Cella, G. Bellotto, F. Tona, and F. , Plasma markers of endothelial dysfunction in pulmonary hypertension Endothelin-1 and functional tissue factor: a possible relationship with severity in primary pulmonary hypertension Thrombotic risk factors in pulmonary hypertension Interpretation of high wedge pressure on exercise in patients with chronic obstructive pulmonary disease Calibrated automated thrombin generation measurement in clotting plasma A new fast one-step immunopreparation for activated protein C Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma, Dahm AE, Andersen TO, Rosendaal F, et al. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI), pp.132-136, 1995.

W. Mahoney, M. Hermodson, and B. Jones, Amino acid sequence and secondary structural analysis of the corn inhibitor of trypsin and activated Hageman Factor, J Biol Chem Jul, vol.10259, issue.13, pp.8412-8418, 1984.

C. Moreira, A. Schmaier, and F. Mahdi, Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator, FEBS Letters, vol.14, issue.1-3, pp.167-70, 2002.
DOI : 10.1002/1097-4644(20001101)79:2<239::AID-JCB70>3.0.CO;2-2

J. Van-veen, A. Gatt, and P. Cooper, Corn trypsin inhibitor in fluorogenic thrombingeneration measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?, Blood Coagul Fibrinolysis Thromb Haemost, vol.219101, issue.606, pp.1954-1963, 2008.

K. Pinto, G. Hafner, H. Schinzel, and W. Ehrenthal, Accuracy of coagulation values obtained from a heparinized central venous catheter Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex, Oncol Nurs Forum Ann Hematol, vol.2167, issue.623, pp.573-5121, 1993.

J. Magnant and E. Diot, Systemic sclerosis: epidemiology and environmental factors

A. Servettaz, C. Agard, and M. Tamby, Systemic sclerosis: pathophysiology of a multifaceted disease] Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients, Presse Med Presse Med Chest, vol.351235131, issue.64121, pp.1894-901217, 2006.

T. Lecompte, D. Wahl, and C. Perret-guillaume, Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk Effect of standardization and normalization on imprecision of calibrated automated thrombography: an internatioanl multicentre study Standardisation of thrombin generation test-which reference plasma for TGT? An international multicentre study, Haematologica Br J Haematol Thromb Res, vol.92139, issue.68, pp.714-5303, 2007.

M. Trossaert, V. Regnault, and M. Sigaud, Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype, Journal of Thrombosis and Haemostasis, vol.95, issue.3, pp.486-93, 2008.
DOI : 10.1111/j.1365-2516.2004.00936.x

A. Membre, D. Wahl, and V. Latger-cannard, The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies, Haematologica, vol.93, issue.4, pp.566-73, 2008.
DOI : 10.3324/haematol.12364

K. Devreese, K. Peerlinck, and J. Arnout, Summary, Thrombosis and Haemostasis, vol.101, issue.01, pp.185-96, 2009.
DOI : 10.1160/TH08-06-0393

K. Devreese, K. Peerlinck, and M. Hoylaerts, Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants, Blood, vol.115, issue.4, pp.870-878, 2010.
DOI : 10.1182/blood-2009-09-244426

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-301674, 2002.
DOI : 10.1183/09031936.04.00010904

H. Ishii, P. Majerus, T. Hackeng, L. Maurissen, and E. Castoldi, Thrombomodulin is present in human plasma and urine Regulation of TFPI function by protein S, J Clin Invest J Thromb Haemost, vol.767, issue.77 1, pp.2178-81165, 1985.

H. Kajimoto, M. Nakazawa, and K. Murasaki, Increased P-Selectin Expression on Platelets and Decreased Plasma Thrombomodulin in Fontan Patients, Circulation Journal, vol.73, issue.9, 2009.
DOI : 10.1253/circj.CJ-08-1087

C. Konstantoulas, J. Cooper, and A. Ohlin, Low soluble thrombomodulin activity and antigen is associated with a family history of heart disease while a high level is associated with a personal history of heart disease in type II diabetes, Thrombosis and Haemostasis, vol.73, issue.9, pp.1705-1715, 2007.
DOI : 10.1160/TH06-03-0160

K. Aksu and H. Aydin, The plasma levels of activated thrombin activatable fibrinolysis inhibitor and thrombomodulin in Behcet Disease and their association with thrombosis Wall tension is a potent negative regulator of in vivo thrombomodulin expression Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism, Thromb Res Circ Res J Thromb Thrombolysis, vol.979227, issue.823, pp.161-441, 2003.

N. Zakai, P. Lutsey, and A. Folsom, Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology, Thromb Haemost, vol.104, issue.2, pp.207-219, 2010.

E. Grabowski, A. Reininger, and P. Petteruti, Shear Stress Decreases Endothelial Cell Tissue Factor Activity by Augmenting Secretion of Tissue Factor Pathway Inhibitor, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.1
DOI : 10.1161/01.ATV.21.1.157

M. Miniati, C. Fiorillo, and M. Becatti, Fibrin Resistance to Lysis in Patients with Pulmonary Hypertension Other Than Thromboembolic, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.9, pp.992-998, 2010.
DOI : 10.1378/chest.06-2674

T. Morris, J. Marsh, and P. Chiles, High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension, Blood Am J Respir Crit Care Med, vol.114177, issue.875, pp.1929-36536, 2008.

P. Diehl, M. Aleker, and T. Helbing, Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants, J Thromb Thrombolysis J Thromb Haemost, vol.5, issue.11, pp.2204-2214, 2007.

N. Galie, M. Hoeper, and M. Humbert, Guidelines for the diagnosis and treatment of pulmonary hypertension Primary pulmonary hypertension: natural history and the importance of thrombosis The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension, Eur Respir J Circulation N Engl J Med, vol.3470327, issue.922, pp.1219-63580, 1984.

=. Pca, C. Protéine, and .. , Comparaison de l'ETP-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes. ETP = Endogenous Thrombin Potential, Figure, vol.30, p.75

=. Pca, C. Protéine, and .. , Comparaison du Pic-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure 31 : (A) Comparaison du Pic pour les patients et les témoins, p.76

=. Pca, C. Protéine, and .. , Comparaison du Temps de latence-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure, vol.32, p.77

=. Pca, C. Protéine, and .. , Comparaison du Temps pour atteindre le pic pour les patients et les témoins Comparaison du Temps pour atteindre le pic-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure, vol.33, p.78

=. Pca, C. Protéine, and .. , Pic sur le Temps pour atteindre le pic pour les patients et les témoins Comparaison du ratio du Pic-PCa sur le Temps pour atteindre le pic-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure, vol.34, p.79

=. Pca, C. Protéine, and .. , Comparaison de l'ETP-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes. ETP = Endogenous Thrombin Potential, Figure, vol.35, p.82

=. Pca, C. Protéine, and .. , Comparaison du Pic-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure 36 : (A) Comparaison du Pic pour les patients et les témoins, p.83

=. Pca, C. Protéine, and .. , Comparaison du Temps de latence-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure, vol.37, p.84

=. Pca, C. Protéine, and .. , Comparaison du Temps pour atteindre le pic pour les patients et les témoins Comparaison du Temps pour atteindre le pic -PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure, vol.38, p.85

=. Pca, C. Protéine, and .. , Pic sur le Temps pour atteindre le pic pour les patients et les témoins Comparaison du ratio du Pic-PCa sur le Temps pour atteindre le pic-PCa pour les patients et les témoins Les lignes représentent les médianes et les nombres indiquent les valeurs correspondantes, Figure, vol.39, p.86

J. Perrin, T. Lecompte, A. Tournier, L. Morlon, M. Marchand-arvier et al., In vitro effects of human neutrophils cathepsin G on the thrombin generation: both acceleration and decreased potential, Thromb Haemost, vol.104, issue.3, pp.514-536, 2010.

J. M. Chaouat, A. Toti, and F. , Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.177, issue.5, pp.536-578, 2008.

T. Lecompte, Caractérisation des microparticules circulantes chez les patients atteints du syndrome des anti-phospholipides. Association Française de Cytométrie

A. Brunette, Etude de l'hypercoagulabilité au cours de l'hypertension artérielle pulmonaire. Doctoriales, 2008.